Sernova Biotherapeutics Inc
SVA
Company Profile
Business description
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.
Contact
700 Collip Circle
Suite 114
LondonONN6G 4X8
CANT: +1 877 299-4603
E: info@sernova.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 October 2025
Employees
17
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,959.70 | 106.00 | 1.35% |
| CAC 40 | 7,225.85 | 121.05 | 1.70% |
| DAX 40 | 20,737.10 | 363.00 | 1.78% |
| Dow JONES (US) | 40,212.71 | 619.05 | 1.56% |
| FTSE 100 | 8,072.98 | 108.80 | 1.37% |
| HKSE | 21,346.68 | 431.99 | 2.07% |
| NASDAQ | 16,724.46 | 337.14 | 2.06% |
| Nikkei 225 | 33,982.36 | 396.78 | 1.18% |
| NZX 50 Index | 12,107.54 | 88.41 | 0.74% |
| S&P 500 | 5,363.36 | 95.31 | 1.81% |
| S&P/ASX 200 | 7,748.60 | 102.10 | 1.34% |
| SSE Composite Index | 3,262.81 | 24.58 | 0.76% |